COXPD33
MCID: CMB082
MIFTS: 21

Combined Oxidative Phosphorylation Deficiency 33 (COXPD33)

Categories: Cardiovascular diseases, Genetic diseases, Metabolic diseases

Aliases & Classifications for Combined Oxidative Phosphorylation Deficiency 33

MalaCards integrated aliases for Combined Oxidative Phosphorylation Deficiency 33:

Name: Combined Oxidative Phosphorylation Deficiency 33 58 76 30 6 17
Coxpd33 58 76

Characteristics:

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
highly variable phenotype
four unrelated patients have been reported (last curated october 2017)
neonatal onset and death in infancy (in some patients)
adult onset (in some patients)


HPO:

33
combined oxidative phosphorylation deficiency 33:
Onset and clinical course adult onset


Classifications:



Summaries for Combined Oxidative Phosphorylation Deficiency 33

UniProtKB/Swiss-Prot : 76 Combined oxidative phosphorylation deficiency 33: An autosomal recessive disorder caused by multiple mitochondrial respiratory chain defects and impaired mitochondrial energy metabolism. Clinical manifestations are highly variable. Affected infants present with cardiomyopathy accompanied by multisystemic features involving liver, kidney, and brain. Death in infancy is observed in some patients. Children and adults present with myopathy and progressive external ophthalmoplegia.

MalaCards based summary : Combined Oxidative Phosphorylation Deficiency 33, is also known as coxpd33. An important gene associated with Combined Oxidative Phosphorylation Deficiency 33 is C1QBP (Complement C1q Binding Protein). Affiliated tissues include kidney, liver and brain, and related phenotypes are elevated hepatic transaminase and nephrotic syndrome

OMIM : 58 COXPD33 is an autosomal recessive multisystem disorder resulting from a defect in mitochondrial energy metabolism. The phenotype is highly variable, ranging from death in infancy to adult-onset progressive external ophthalmoplegia (PEO) and myopathy. A common finding is cardiomyopathy and increased serum lactate (summary by Feichtinger et al., 2017). For a discussion of genetic heterogeneity of combined oxidative phosphorylation deficiency, see COXPD1 (609060). (617713)

Related Diseases for Combined Oxidative Phosphorylation Deficiency 33

Symptoms & Phenotypes for Combined Oxidative Phosphorylation Deficiency 33

Human phenotypes related to Combined Oxidative Phosphorylation Deficiency 33:

33 (show all 14)
# Description HPO Frequency HPO Source Accession
1 elevated hepatic transaminase 33 very rare (1%) HP:0002910
2 nephrotic syndrome 33 very rare (1%) HP:0000100
3 ptosis 33 HP:0000508
4 myopathy 33 HP:0003198
5 fatigue 33 HP:0012378
6 cardiomegaly 33 HP:0001640
7 cardiomyopathy 33 HP:0001638
8 increased serum lactate 33 HP:0002151
9 progressive external ophthalmoplegia 33 HP:0000590
10 left ventricular hypertrophy 33 HP:0001712
11 amblyopia 33 HP:0000646
12 astigmatism 33 HP:0000483
13 exercise intolerance 33 HP:0003546
14 elevated serum creatine kinase 33 HP:0003236

Symptoms via clinical synopsis from OMIM:

58
Head And Neck Eyes:
ptosis
progressive external ophthalmoplegia
amblyopia
astigmatism

Cardiovascular Heart:
cardiomegaly
cardiomyopathy
left ventricular hypertrophy

Metabolic Features:
metabolic acidosis

Abdomen Liver:
hepatomegaly (1 patient)

Genitourinary Kidneys:
nephrosis (1 patient)
kidney failure (1 patient)

Endocrine Features:
hypothyroidism (1 patient)

Muscle Soft Tissue:
myopathy
exercise intolerance
weakness
easy fatigue

Laboratory Abnormalities:
increased serum lactate
increased serum creatine kinase
abnormal liver enzymes (in some patients)
combined deficiency of mitochondrial respiratory complex activity, variable
mtdna depletion (in some patients)

Head And Neck Ears:
sensorineural hearing loss (1 patient)

Respiratory:
cardiorespiratory insufficiency

Neurologic Peripheral Nervous System:
sensory peripheral neuropathy (in some patients)

Prenatal Manifestations Amniotic Fluid:
oligohydramnios (in some affected pregnancies)

Clinical features from OMIM:

617713

Drugs & Therapeutics for Combined Oxidative Phosphorylation Deficiency 33

Search Clinical Trials , NIH Clinical Center for Combined Oxidative Phosphorylation Deficiency 33

Genetic Tests for Combined Oxidative Phosphorylation Deficiency 33

Genetic tests related to Combined Oxidative Phosphorylation Deficiency 33:

# Genetic test Affiliating Genes
1 Combined Oxidative Phosphorylation Deficiency 33 30 C1QBP

Anatomical Context for Combined Oxidative Phosphorylation Deficiency 33

MalaCards organs/tissues related to Combined Oxidative Phosphorylation Deficiency 33:

42
Kidney, Liver, Brain

Publications for Combined Oxidative Phosphorylation Deficiency 33

Articles related to Combined Oxidative Phosphorylation Deficiency 33:

# Title Authors Year
1
Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies. ( 28942965 )
2017

Variations for Combined Oxidative Phosphorylation Deficiency 33

UniProtKB/Swiss-Prot genetic disease variations for Combined Oxidative Phosphorylation Deficiency 33:

76
# Symbol AA change Variation ID SNP ID
1 C1QBP p.Gly247Trp VAR_080394
2 C1QBP p.Leu275Pro VAR_080396

ClinVar genetic disease variations for Combined Oxidative Phosphorylation Deficiency 33:

6 (show all 12)
# Gene Variation Type Significance SNP ID Assembly Location
1 C1QBP NM_001212.3(C1QBP): c.557G> C (p.Cys186Ser) single nucleotide variant Pathogenic rs748497469 GRCh38 Chromosome 17, 5433688: 5433688
2 C1QBP NM_001212.3(C1QBP): c.557G> C (p.Cys186Ser) single nucleotide variant Pathogenic rs748497469 GRCh37 Chromosome 17, 5337008: 5337008
3 C1QBP NM_001212.3(C1QBP): c.612C> G (p.Phe204Leu) single nucleotide variant Pathogenic rs767427194 GRCh37 Chromosome 17, 5336700: 5336700
4 C1QBP NM_001212.3(C1QBP): c.612C> G (p.Phe204Leu) single nucleotide variant Pathogenic rs767427194 GRCh38 Chromosome 17, 5433380: 5433380
5 C1QBP NM_001212.3(C1QBP): c.824T> C (p.Leu275Pro) single nucleotide variant Pathogenic rs1555532483 GRCh37 Chromosome 17, 5336360: 5336360
6 C1QBP NM_001212.3(C1QBP): c.824T> C (p.Leu275Pro) single nucleotide variant Pathogenic rs1555532483 GRCh38 Chromosome 17, 5433040: 5433040
7 C1QBP NM_001212.3(C1QBP): c.739G> T (p.Gly247Trp) single nucleotide variant Pathogenic rs1394499137 GRCh38 Chromosome 17, 5433125: 5433125
8 C1QBP NM_001212.3(C1QBP): c.739G> T (p.Gly247Trp) single nucleotide variant Pathogenic rs1394499137 GRCh37 Chromosome 17, 5336445: 5336445
9 C1QBP NM_001212.3(C1QBP): c.823C> T (p.Leu275Phe) single nucleotide variant Pathogenic rs1555532484 GRCh37 Chromosome 17, 5336361: 5336361
10 C1QBP NM_001212.3(C1QBP): c.823C> T (p.Leu275Phe) single nucleotide variant Pathogenic rs1555532484 GRCh38 Chromosome 17, 5433041: 5433041
11 C1QBP NM_001212.3(C1QBP): c.562_564delTAT (p.Tyr188del) deletion Pathogenic rs755568057 GRCh37 Chromosome 17, 5337001: 5337003
12 C1QBP NM_001212.3(C1QBP): c.562_564delTAT (p.Tyr188del) deletion Pathogenic rs755568057 GRCh38 Chromosome 17, 5433681: 5433683

Expression for Combined Oxidative Phosphorylation Deficiency 33

Search GEO for disease gene expression data for Combined Oxidative Phosphorylation Deficiency 33.

Pathways for Combined Oxidative Phosphorylation Deficiency 33

GO Terms for Combined Oxidative Phosphorylation Deficiency 33

Sources for Combined Oxidative Phosphorylation Deficiency 33

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....